MedPath

PHENERGAN EXPECTORANT WITH CODEINE LIQ

PHENERGAN EXPECTORANT WITH CODEINE LIQ

Discontinued
DIN Number

01937545

Drug Class

Human

Market Date

Dec 31, 1993

Company
HC

rhone-poulenc rorer consumer inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number01937545
AIG Number0311735001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic
A
ATC Code
R05FA02 OPIUM DERIVATIVES AND EXPECTORANTS
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification48:08.00
Health Canada Classification

ACTIVE INGREDIENTS (3)

CODEINE PHOSPHATEActive
Strength: 10 MG / 5 ML
Monograph: CODEINE PHOSPHATE
POTASSIUM GUAIACOL SULPHONATEActive
Strength: 40 MG / 5 ML
Monograph: POTASSIUM GUAIACOL SULPHONATE
PROMETHAZINE HYDROCHLORIDEActive
Strength: 5.65 MG / 5 ML
Monograph: PROMETHAZINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.